Indianapolis, IN, United States of America

J Geoffrey Swope

This inventor holds 10 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J Geoffrey Swope. Retrieved from https://idiyas.com/inventor/j-geoffrey-swope

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 70.0

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of J Geoffrey Swope

Introduction

J Geoffrey Swope is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of innovation, holding a total of 10 patents. His work primarily focuses on advancements in the pharmaceutical industry, where he has been instrumental in developing new solutions.

Latest Patents

Among his latest patents, J Geoffrey Swope has been involved in creating innovative labels that enhance product identification and safety. These patents reflect his commitment to improving the efficacy and reliability of pharmaceutical products.

Career Highlights

Swope's career is marked by his association with Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly has allowed him to collaborate with some of the brightest minds in the industry, driving forward the boundaries of medical science.

Collaborations

Throughout his career, J Geoffrey Swope has worked alongside talented colleagues such as Ross Stephen Merkel and Joseph Vito Primiani. These collaborations have fostered a creative environment that has led to numerous successful innovations.

Conclusion

J Geoffrey Swope's contributions to the field of invention and innovation are noteworthy. His work at Eli Lilly and Company, along with his impressive portfolio of patents, showcases his dedication to advancing pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…